Kobuke, Makoto, Saika, Takashi, Nakanishi, Yoshiko, Ebara, Shin, Manabe, Daisuke, Uesugi, Tatsuya, ...
To determine health-related quality of life (HRQOL) after radical retropubic prostatectomy (RRP) or permanent prostate brachytherapy (BT), third party-conducted QOL surveys were prospectively...
Saika, Takashi, Kobayashi, Yasuyuki, Watanabe, Toyohiko, Manabe, Daisuke, Ebara, Shin, Uehara, Shinya, ...
To evaluate morbidity in Hybrid Radical Prostatectomy (HRP, hybridized laparoscopic and open retropubic radical prostatectomy). The operative and pathological outcomes obtained in 25 consecutive...
Ebara, Shin, Katayama, Yoshihisa, Tanimoto, Ryuta, Edamura, Kohei, Nose, Hiroyuki, Manabe, Daisuke, ...
From January 2004 to March 2007, 308 patients with clinically localized prostate cancer were treated using iodine-125 (125I) seed implantation (permanent brachytherapy) at Okayama University Graduate...
Murakami, Takanori, Ebara, Shin, Saika, Takashi, Irie, Shin, Takeda, Katsuji, Maki, Yoshio, ...
We evaluated the need for transurethral biopsy at first follow-up after intravesical bacillus Calmette-Guerin (BCG) therapy for superficial bladder cancer. The records of 84 patients with superficial...
Ebara, Shin, Manabe, Daisuke, Kobayashi, Yasuyuki, Tanimoto, Ryuta, Saika, Takashi, Nasu, Yasutomo, ...
From September 2003 to December 2005, 188 patients who visited our hospital and allied institutions for the purpose of prostate brachytherapy were administrated hormonal therapy for volume reductions...
Edamura, Kohei, Saika, Takashi, Senoh, Takashi, Koizumi, Fumihito, Manabe, Daisuke, Ebara, Shin, ...
This study was undertaken to reveal the trends of prostate cancer and the outcome of treatment modalities for each disease stage in patients in a single institute over a 10-year period. From January...
Kaku, Haruki, Saika, Takashi, Tsushima, Tomoyasu, Nagai, Atsushi, Yokoyama, Teruhiko, Abarzua, Fernando, ...
We evaluated the efficiency and toxicity of estramustine phosphate (ECT), ifosfamide (IFM) and cisplatin (CDDP) combination chemotherapy in twenty-one patients with hormone-refractory prostate cancer...